Verrica Pharmaceuticals said late Thursday that a late-breaking abstract reporting phase 2 exploratory data of VP-315 for the treatment of basal cell carcinoma was accepted. The company said the...
U.S. equity futures were slightly lower to flat ahead of the open. Nasdaq futures showed mild weakness after the sharp rally earlier in the week. S&P 500 and Dow futures were near unchanged to slightly negative.
Core Laboratories (NYSE:CLB – Get Free Report) updated its first quarter 2026 earnings guidance on Thursday. The company provided EPS guidance of 0.050-0.070 for the period, compared to the consensus EPS estimate of 0.160. The company issued revenue guidance of $119.0 million-$123.0 million, compared
CSL shares have tumbled again. The post CSL shares: 3 reasons to buy and 3 reasons to sell appeared first on The Motley Fool Australia . Read Full Article →
The House Labor Committee voted to kill a bill that would have established a state minimum wage starting at $12. Read Full Article →
